4//SEC Filing
Loose Christopher R. 4
Accession 0001127602-23-020573
CIK 0001703647other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 5:35 PM ET
Size
14.4 KB
Accession
0001127602-23-020573
Insider Transaction Report
Form 4
Loose Christopher R.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2023-07-10+4,546→ 70,569 total - Exercise/Conversion
Restricted Stock Unit
2023-07-07−4,546→ 136,362 total→ Common Stock (4,546 underlying) - Sale
Common Stock
2023-07-07$0.36/sh−1,306$470→ 62,781 total - Exercise/Conversion
Common Stock
2023-07-07+4,546→ 67,327 total - Sale
Common Stock
2023-07-10$0.37/sh−1,304$482→ 66,023 total - Exercise/Conversion
Restricted Stock Unit
2023-07-10−4,546→ 131,816 total→ Common Stock (4,546 underlying)
Footnotes (6)
- [F1]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.34 to $0.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]Includes 6,329 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F5]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.37 to $0.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F6]The restricted stock units will fully vest on July 4, 2023.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001785299
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 5:35 PM ET
- Size
- 14.4 KB